Structural Formula (Image 01)
Xatmep Solution
Product Images NDC 52652-2001
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Xatmep (NDC 52652-2001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Azurity Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (Bottle Label)
Xatmep is an oral solution used for the treatment of various types of cancer. It contains methotrexate, which is a cytotoxic agent that works by stopping the growth of cancer cells. The usual dose of Xatmep is determined by the prescribing physician. It is important to keep this medication out of the reach of children and store it in the refrigerator. However, patients may store it at room temperature for up to 60 days before discarding it.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
